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ABSTRACT The response of the steady-state level of mitochondrial NAD(P)H of individual cardiac myocytes to substrate
and to pharmacological alteration of intracellular calcium was investigated using a defined pacing protocol. Rapid pacing (5
Hz) reversibly decreased the NAD(P)H level and increased oxygen consumption whereas phosphocreatine and ATP levels did
not change significantly. Verapamil plus NiCI2 blockade of calcium channels abolished contractions. Ryanodine, which
prevents calcium-induced calcium release, also stopped cell contraction. NAD(P)H levels do not change in the absence of
contraction. Blockade of sarcolemmal K+ channels did not stop contraction, and NAD(P)H levels reversibly decreased during
rapid pacing. Thus rapid contractions are associated with a reversible decrease in NAD(P)H levels. Ruthenium red blockade
of Ca2+ entry into mitochondria did not block contraction but significantly decreased NAD(P)H levels in both slowly paced (0.5
Hz) and rapidly paced cells. The simplest explanation of these data is that the steady-state reduction of NAD(P)H is strongly
dependent on the rate of ATP utilization and not on sarcoplasmic Ca2+ levels when the oxygen and substrate supplies are
not limiting and the intracellular calcium regulation is maintained. An effect of intracellular Ca2+ on NAD(P)H is observed only
when Ca2+ entry into mitochondria is blocked with ruthenium red.
INTRODUCTION
The rate of oxidative phosphorylation by cardiac mitochon-
dria must keep pace with changing rates of ATP utilization
imposed by changing work output. Many parameters of
mitochondrial function may adjust to achieve this change.
Here we focus attention on the steady-state extent of reduc-
tion of mitochondrial NAD(P)H/NAD(P). Reducing equiv-
alents from many substrate dehydrogenation reactions enter
the mitochondrial electron transport chain through
NAD(P)H/NAD(P). This large pool (- 1-2 mM) is in near
equilibrium with reactions of many mitochondrial chain
enzymes (Ugurbil and From, 1993), and its state of reduc-
tion depends on the balance between the rates of oxygen
supply, substrate supply, and ATP utilization. When the
delivery of oxygen to cytochrome oxidase is not limiting,
the steady-state level of reduction of NAD(P) to NAD(P)H
reflects the balance between the rate of inflow of reducing
equivalents from substrate and the rate of dissipation of the
electrochemical gradient across the mitochondrial inner
membrane (AlA) by the action of mitochondrial ATP syn-
thase.
In the heart, voltage-dependent sarcolemmal calcium
channels open with each depolarization, permitting calcium
to enter the cell and activate a large spike of calcium release
from the sarcoplasmic reticulum, relieving troponin inhibi-
tion and initiating contraction and ATP utilization by acto-
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myosin ATPase (Hille, 1984). Calcium uptake by the sar-
coplasmic reticulum and Na/Ca exchange across the
sarcolemma return sarcoplasmic calcium to diastolic levels.
Mitochondrial reactions catalyzed by pyruvate (PDH),
a-ketoglutarate, and isocitrate (ICDH) dehydrogenases may
be activated by increased mitochondrial Ca2+. Both (mean)
cytosolic and mitochondrial Ca2+ increase in cardiac myo-
cytes when cells are paced rapidly in the presence of ,3-ad-
renergic agonists. Under these conditions, the active form of
PDH is reported to increase (Di Lisa et al., 1993). However,
in earlier experiments using glucose as the sole substrate
(White and Wittenberg, 1993), steady-state levels of
NAD(P)H actually decreased during pacing. Thus activa-
tion of mitochondrial dehydrogenase activity during pacing
enhances the rate of substrate dehydrogenation but does not
increase the steady-state level of mitochondrial NAD(P)H.
Harris and Das (1991) report that the capacity of ATPase/
synthase is increased in a calcium-dependent manner during
stimulation of cultured cardiac myocytes, and Scholz and
Balaban (1994) report that F1-ATPase activity is increased
by 30% in whole heart beating in the presence of ,3-adren-
ergic agonists. The suggestion is that increased sarcoplas-
mic calcium during pacing will activate ATP synthase ca-
pacity, thus permitting a higher maximal rate of ATP
synthesis during increased demand. A higher ATP synthase
rate will increase the rate of dissipation of the mitochondrial
electrochemical gradient (Ag), and a decrease in A,A will be
reflected in a decrease in NAD(P)H as a consequence of the
interconnection of these two substrates by near-equilibrium
reactions. This suggested that increased mitochondrial cal-
cium during pacing might increase mitochondrial NAD(P)H
if the dehydrogenase activation by Ca2+ dominates and
might decrease mitochondrial NAD(P)H if the ATPase/
synthase activation dominates. No change in NAD(P)H
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would indicate a balance achieved by a matched calcium-
dependent stimulation of both reactions (Harris and Das,
1991).
In this report we use single cells freshly isolated from
adult rat heart to test the effects of modulation of intracel-
lular calcium on steady-state levels of NAD(P)H using a
standardized protocol where oxygen and substrate availabil-
ity are made not limiting and ATP utilization is increased
reversibly. Ruthenium red is used to inhibit calcium trans-
port into mitochondria (Moore, 1971; Gunther and Pfeiffer,
1990), thus preventing calcium-dependent activation of
both mitochondrial dehydrogenases and ATPase/synthase.
The simplest explanation of the findings of the present
experiments is that the steady-state reduction of mitochon-
drial NAD(P)H during pacing is strongly dependent on the
rate of ATP utilization at the myofilaments and not on
sarcoplasmic Ca2+ levels. At the unphysiologically low
mitochondrial calcium levels achieved with ruthenium red,
the effect of calcium to stimulate mitochondrial dehydroge-
nases dominates the level of NAD(P)H. An effect of intra-
cellular Ca2+ on mitochondrial NAD(P)H levels is observed
only when Ca2+ entry into mitochondria is blocked with
ruthenium red.
MATERIALS AND METHODS
Ruthenium red was obtained from Sigma (St. Louis, MO). The purity was
15.3% on the basis of absorbance spectra using an extinction of 792 at 532
nm for 1% ruthenium red (Luft, 1971). The concentration used here, 6
,ug/ml of 15.3% ruthenium red, is equivalent to 1.2 ,M of 100% ruthenium
red. All other reagents were purchased from Sigma unless specified oth-
erwise.
Dissociation of the heart into cells
Heart cells were prepared by a modification of the procedure of White and
Wittenberg (1993). Retrograde aortic perfusion of the heart was begun
immediately after removal with HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid, pH = 7.5)-buffered minimal essential medium
(MEM) containing 117 mM NaCl, 5.7 mM KCI, 4.4 mM NaHCO3, 1.5
mM NaH2PO4, 1.7 mM MgCl2, 21.1 mM HEPES, 5.4 mM glucose, amino
acids and vitamins, 2 mM L-glutamine, and 10 mM taurine; the pH was
adjusted to 7.2 with NaOH. All solutions were prepared with American
Society of Tests and Materials type I water produced by treating house-
distilled water with a commercial mixed-bed ion exchanger followed by a
charcoal filter and finally a Millipore filter. This solution was 292 mOsm,
and the free calcium activity was 2-5 ,uM, as measured with a Moller
(Zurich, Switzerland) calcium ion-selective electrode. For the perfusion
steps, we added 10 ,LM CaCl2 to MEM to give a final calcium activity of
7 ,uM. After blood washout, the perfusion medium was supplemented with
0.045% collagenase (Boehringer Mannheim type B; batches are selected
for a high yield of viable myocytes). This solution was recirculated at 7
ml/min for 25 min. All perfusion solutions were maintained at 32°C and
equilibrated with a water-saturated 85% 02/15% N2 gas mixture. The heart
was removed from the perfusion apparatus and cut into 8-10 pieces in 10
ml incubation medium containing 0.09% collagenase. The composition of
incubation medium was the same as MEM (above), with the addition of 1.0
mM CaCl2 and 0.5% bovine serum albumin (BSA, Fraction V). The
suspension was gently swirled in 50 ml Erlenmeyer flasks at 32°C by a
wrist-action shaker. Cells were decanted from the tissue, washed by low-
speed centrifugation (34 X g) to complete removal of collagenase and
some subcellular debris, and suspended in incubation medium. Incubation
of the tissue suspension with collagenase was repeated at least two more
times. After being washed, the cells were purified with Percoll (Pharmacia
Fine Chemicals, Uppsala Sweden). Cells were suspended in isotonic Per-
coll diluted with incubation medium to a final concentration of 0.2-0.4 X
106 cells/ml and 41% Percoll. Ten-milliliter portions of the Percoll-cell
suspension in 15 ml Corex centrifuge tubes were centrifuged at room
temperature for 10 min at 34 X g. Intact rectangular cells sedimented to the
bottom of the tube, and rounded cells formed a distinct layer at the surface.
The pellet of intact cells was washed to remove Percoll, suspended in
incubation medium, and maintained at 34°C. The yield was 1.5 ± 0.7 X
107 cells per heart; 89.5 ± 0.8% (n = 12 hearts) of the ventricular
myocytes were rectangular. Sarcomere lengths were 1.98 ± 0.12 Am (n =
10 cells). Cells contracted and relengthened specifically in response to
electrical stimulation (15 V/mm, 6 ms duration) and were quiescent oth-
erwise.
Measurements of mitochondrial NADH with
a microfluorimeter
The mitochondrial NAD(P)H level is defined as the ratio of NADH
fluorescence measured at a particular condition divided by the maximal
NADH observed in the presence of 10 ,uM rotenone at 230C.
The measurement of mitochondrial NAD(P)H of single cells by fluo-
rescence was described previously (White and Wittenberg, 1993). Briefly,
an inverted microscope (Nikon Diaphot, Garden City, NY) equipped with
an epifluorescence attachment and dual photomultiplier tubes was used as
a microfluorimeter to record intrinsic fluorescence spectra from single
myocytes at two wavelengths (415 and 470 nm). Fluorescence emission
from a single myocyte was isolated using a mask with a rectangular
opening of constant size in the light path. The currents from the two
photomultipliers were converted to voltages, filtered, and then digitized
(256 samples in 50 ms, 12-bit resolution). Optimal resolution of NADH
was observed at 470 nm and recorded by photomultiplier 1. Intrinsic cell
fluorescence (cell background) was measured at 415 nm, a wavelength
isoemissive for oxymyoglobin and deoxymyoglobin. As recorded by pho-
tomultiplier 2, this value served as a reference to compensate for motion
artifacts, differences in cell thickness, and light scattering. The duration of
illumination, the sampling rate, and the number of samples digitized were
selected to avoid bleaching of the NADH fluorescence and to average
noise. The mean difference (256 samples) between the signals from pho-
tomultipliers 1 and 2 was used to calculate NADH. We previously pre-
sented a calibration curve showing that this method gives a linear relation-
ship with standard solutions of NADH/NAD mixtures (White and
Wittenberg, 1993). The background fluorescence from the medium was
recorded at 470 and 415 nm in the absence of a cell image in the
observation area and was subtracted from the cell image signal from each
photomultiplier. Maximum NADH fluorescence was recorded from 10 P,M
rotenone-treated cells. Minimum NADH fluorescence (usually near zero)
was recorded from single "rounded" cells.
Cells (1 X 104 total cells) in the perfusion chamber on the microscope
stage were superfused with MEM supplemented with 9.5 mM NaHCO3
(total 15 mM), 1 mM CaC12 (total 2 mM), 0.05 AM arterenol, and 2 mM
(3-hydroxybutyrate ((3-OH butyrate) (except the experiment described in
Fig. 1) at 23°C. The superfusion medium was equilibrated with 95%
02/5% CO2 for the duration of the experiment. Platinum-iridium electrodes
at the bottom of the chamber delivered bipolar stimulation pulses. Cells
were equilibrated for 20 min at the pacing rate indicated before the initial
NAD(P)H measurement was recorded from six identifiable cells between
the stimulating electrodes. The selected cells were followed individually
throughout each experiment. The stimulation rate was increased to 5 Hz
(300 beats/min), and NAD(P)H in the same six cells was measured during
pacing after 10 min. To demonstrate reversibility, the rate of electrical
stimulation was reduced to the initial rate for 20 min, and a final measure-
ment of NAD(P)H was recorded from each cell.
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Oxygen consumption measurements
Oxygen partial pressure (PO2) was measured with a small (0.125-inch body
diameter) polarographic membrane-covered oxygen-sensing electrode. The
electrode (Instech Corp., Plymouth Meeting, PA) was placed near the
bottom of the observation chamber between the stimulating electrodes in
the downfield path of the superfusate flow. The oxygen electrode was
calibrated with superfusion medium gas-equilibrated with 95% oxygen/5s%
C02, 95% air/5% CO2, and 95% nitrogen/5% CO2 gas mixtures. The
response was linear throughout this range. Electrical pulses from the
stimulator did not affect oxygen electrode readings in the absence of cells.
Superfusion medium equilibrated with 95% 02/5% CO2 was passed
through the chamber at a flow rate of 1.7 ml/min. Cells (1.25 X 105) were
added to the chamber and allowed to settle, and superfusion was restarted
with medium equilibrated with 95% oxygen/5% CO2. P02 was recorded at
steady state: before the cells were added (Pi), after equilibration of the cells
in the absence of stimulation (P2), and during stimulation at 0.5 Hz (p3) and
5.0 Hz (p4). Stimulation was then decreased to 0.5 Hz and finally stopped
to repeat measurements p3 and P2-
The steady-state Po2 in the dish, in the presence of cells, reflects the
oxygen supplied by the superfusing medium minus diffusive loss of oxy-
gen from the dish minus cellular uptake of oxygen by the cells. Therefore
the difference in P02 with no cells in the dish minus P02 in the presence of
cells reflects the cellular respiratory oxygen uptake. The difference in
steady-state Po2 measured at each pacing rate is normalized to the Po2
difference (Pi minus P2) observed with cells at rest. This normalized value
is a measure of the ratio of cell respiration during pacing relative to resting
respiration. Thus Pi - P3/P1 - P2 = normalized respiratory oxygen
consumption of cells paced at 0.5 Hz. Pi - P4/P1 - P2 = normalized
respiratory oxygen consumption of cells paced at 5 Hz.
Measurements of phosphocreatine
(PCr)/ATP ratio
For analyses of populations of resting cells, portions of the heart cell
suspension (2 1.5 X 106 cells) were deproteinized with ice-cold perchloric
acid. In order to compare PCr/ATP ratios in stimulated heart cells with
unstimulated controls, 0.45 X 106 cells were superfused in the microscope
perfusion chamber, as described above. Control cells were perfused for 30
min without stimulation and then removed for deproteinization and high-
pressure liquid chromatography analysis. Stimulated cells were perfused
for 20 min without stimulation, then stimulated for 10 min at 5 Hz, and
removed for deproteinization and high-pressure liquid chromatography
analysis. A 0.1-ml portion of the neutralized deproteinized extract was
filtered and analyzed by high-pressure liquid chromatography. ATP and
PCr were separated on an anion-exchange column (Whatman (Hillsboro,
OR) Partisil SAX 10, 15-cm long) using 5 mM NH4PO4, pH 2.85, for 10
min at 1 ml/min, followed by a linear gradient to 750mM NH4PO4, pH 4.4,
for 25 min at 2 ml/min. PCr is eluted near 18 min, and ATP is eluted near
30 min.
Statistical analysis
Results are presented as mean + SE. The null hypothesis for data obtained
with treatments on different hearts was tested using Student's t-test (un-
paired). The null hypothesis for data obtained in measurements of the same
cells during different rates of pacing was determined using the paired t-test.
The paired t-test was also used to determine the statistical significance of
different interventions carried out on cells from the same heart preparation.
Data are considered significantly different when p ' 0.05.
RESULTS
In an earlier study (White and Wittenberg, 1993), we used
5.4 mM glucose and 2 mM glutamine as the sole exogenous
substrates. We now find that the addition of 2 mM 3-OH
butyrate substantially increases the NADH and PCr levels in
the cells. The ratio of PCr to ATP is increased significantly
from 1.77 ± 0.09 to 1.95 + 0.08 (p < 0.0001; n = 25
hearts). The fractional reduction of mitochondrial
NAD(P)H in resting cells increased significantly from 0.22
± 0.03 to 0.41 ± 0.03 (p <0.0001; n = 23 for glucose, n
= 28 for (3-OH butyrate plus glucose; Fig. 1). With either
substrate regimen, mitochondrial NAD(P)H was signifi-
cantly and reversibly decreased -30% from the resting state
by electrical stimulation at 5 Hz (p' 0.0008). The quan-
titative change in mitochondrial NAD(P)H between the
resting and stimulated states was 0.08 in the absence of
13-OH butyrate and 0.10 in its presence. These differences
are are not significantly different (p = 0.53). The extent of
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FIGURE 1 The effects of extracellular substrate on mitochondrial
NAD(P)H of single cardiac myocytes. Cells were superfused with medium
equilibrated with 95% 02/5% CO2. Cells were stimulated at 5 Hz after an
initial rest period with no stimulation. Stimulation was turned off for the
20-min recovery. Supplementing the medium with /3-OH butyrate strongly
increased mitochondrial NAD(P)H of cells at rest (p ' 0.0001), during
pacing (p < .00041), and after recovery (p ' 0.0020). With both sub-
strates, NAD(P)H is significantly and reversibly decreased during pacing
(p s 0.0006, n = 29 in the presence of glucose alone; p ' 0.0008, n = 23
in the presence of both glucose and ,3-OH butyrate). * = significantly
different from the rest, within treatment groups. t = significantly different
from glucose alone, with the same rate of stimulation. Data are mean + SE.
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reduction of NAD(P) was not significantly different during
the initial rest and final recovery periods, indicating that the
effect of contraction was reversible.
To more closely approximate the situation in the beating
heart, we carried out all subsequent experiments in glucose
medium supplemented with 2 mM 1-OH butyrate. We also
maintained slow-paced contractions at 0.5 Hz (30 beats/
min) during the initial and recovery phases. Mitochondrial
NAD(P)H levels were the same as those obtained with no
pacing (compare light gray bars in Figs. 1 and 2). Our new
pacing protocol is a 20-min period of 0.5 Hz pacing fol-
lowed by 10 min of rapid pacing at 5 Hz followed by a
recovery phase of 20 min at 0.5 Hz. Mitochondrial
NAD(P)H levels were not significantly different with this
new pacing protocol (n = 26) compared with the resting to
rapid stimulation protocol used previously (n = 18).
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FIGURE 2 The effect of ryanodine on mitochondrial NAD(P)H of single
cardiac myocytes. Ryanodine blocks the sarcoplasmic release channel and
thus calcium-induced calcium release. Superfusion of isolated myocytes
with 5 ,uM ryanodine stops contraction. Initially cells were slowly stimu-
lated at 0.5 Hz for 20 min. Stimulation was increased to 5 Hz during the
next 10 min, and then stimulation was reduced to 0.5 Hz for 20 min.
Mitochondrial NAD(P)H does not change significantly when stimulation is
increased from 0.5 to 5 Hz (n = 14), in contrast to control (light bars).
* = significantly different from initial value, within the same treatment
group. t = significantly different from control, with same rate of stimu-
lation. Data are mean + SE.
Fig. 2 shows the effects of 5 ,uM ryanodine on isolated
heart cells. Ryanodine is known to block the sarcoplasmic
reticulum calcium-release channel at this concentration and
thus calcium-induced calcium release. We find that in the
presence of ryanodine, cells do not contract in response to
electrical stimulation. Mitochondrial NAD(P)H is not
changed during rapid electrical pacing (in contrast to con-
trol). PCr/ATP was not significantly altered by the addition
of ryanodine (p > 0.05; n = 4 hearts).
The blocking of sarcolemmal calcium channels with
verapamil (10 ,uM) plus NiCl2 (50 ,uM) also stopped con-
tractions in response to electrical stimulation. Mitochondrial
NAD(P)H did not decrease in response to increased electri-
cal pacing. There was no significant difference in mitochon-
drial NAD(P)H before and after 5 Hz pacing; the response
to pacing was completely reversible (data not shown). PCr/
ATP was not significantly altered by the addition of vera-
pamil plus NiCl2 (p > 0.05; n = three hearts). These results
are entirely similar to those with ryanodine.
Fig. 3 shows the effects of blocking sarcolemmal K+
channels with 5 mM tetraethylammonium bromide (TEA)
plus 50 ,tM 4-aminopyridine (4-AMP). In contrast to ry-
anodine or verapamil plus NiCl, the addition of K+ channel
blockers did not stop contractions or the reversible decrease
in mitochondrial NAD(P)H in response to increased pacing.
Cells became shortened toward the end of the 5-Hz pacing;
contractions were incomplete. Although mitochondrial
NAD(P)H increased during "recovery," it did not return to
initial values in the 20-min time period allocated. PCr/ATP
was not different in resting cells in the absence or presence
of TEA plus 4-AMP (n = three hearts).
Mitochondrial NAD(P)H decreased reversibly in re-
sponse to pacing at 5 Hz in cells treated with 6 ,ug/ml
ruthenium red (Fig. 4). Unlike control cells, mitochondrial
NAD(P)H did not fully return to control values during
recovery. It is notable that mitochondrial NAD(P)H is sig-
nificantly decreased from control values in the presence of
6 jig/ml ruthenium red during both the slow-paced and the
rapidly paced phases of the protocol. PCr/ATP was not
significantly changed by the addition of 6 ,g/ml ruthenium
red to resting heart cells (p > 0.05; n = 15 hearts). Table 1
shows that during 5 Hz stimulation in these well oxygenated
cells, the PCr/ATP level dropped slightly but not signifi-
cantly in both the presence and the absence of ruthenium
red.
Ruthenium red is known to inhibit calcium entry into
mitochondria (Gunther and Pfeiffer, 1990). To confirm the
appropriateness of the dose, mitochondria were prepared by
a modification of the method of Berkich et al. (1991).
Mitochondria suspended in solutions containing 1 mM
CaCl2 become uncoupled (maximally activated respiration
in the absence of added ADP as measured by polarographic
02 uptake). Ruthenium red (0.1 ,ug/ml) partially blocks and
0.5 ,ug/ml ruthenium red completely blocks calcium-in-
duced uncoupling. This shows that 0.5 ,ug/ml ruthenium red
is sufficient to block calcium entry into isolated mitochon-
L.A-a
White and Wittenberg 2793
Volume 69 December 1995
sl control
sl-aced TEA 4AMP
slow-paced
_~
~~~~ I
.5
.4
0
0
0
0a .3-
C!
4-%
0
0
0
:CtV .J1
20 min
5 Hz-Paced
:
.
..I .:
30 min
Cumulative Time
*T
CZ
0
'4-4
0
*s=
z
0.
C0
CZ
,5
0
CJu
._
.5
.4
3
.2
.1
0J
50 min
FIGURE 3 The effects of potassium channel blockers on mitochon-
drial NAD(P)H of single cardiac myocytes. Heart cells treated with 5
mM tetraethylammonium bromide (TEA) plus 50 ,uM 4-AMP, agents
that block sarcolemmal K+ channels, continue to contract in response to
pacing. Sarcoplasmic Ca21 will increase as a consequence of the
prolonged cardiac action potential induced by these agents. Mitochon-
drial NAD(P)H in cells treated with TEA plus 4-AMP is significantly
decreased during pacing (p ' 0.0084; n = 6), with partial (incomplete)
return to initial levels after 20-min recovery. * = significantly different
from initial levels, within treatment groups. t = significantly different
from control cells, at the same rate of stimulation. Data are mean ± SE.
Perfusion and stimulation protocols were the same as those described in
Fig. 2.
dria and confirms that the dose of 6 ,tg/ml used in our heart
cell experiments is reasonable.
Fig. 5 shows the effect of pacing at 0.5 and 5 Hz on the
oxygen consumption of heart cells in the microfluorim-
eter chamber. Each oxygen uptake measurement is nor-
malized to the resting oxygen uptake measured before
and after stimulation in the same experiment. The P02 of
the medium drops rapidly to a new steady state during
pacing with 0.5 Hz and drops again to a new steady state
during 5 Hz pacing. The P02 of the medium was never
below 20 mm Hg even during 5 Hz stimulation. Note that
stimulation at 0.5 Hz in the presence of 50 nM norepi-
nephrine increases oxygen uptake about threefold com-
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FIGURE 4 The effects of ruthenium red on mitochondrial NADH in
single heart cells. Calcium entry into mitochondria through the
uniporter is inhibited by ruthenium red. Mitochondrial NAD(P)H in the
presence of 6 jig/ml of ruthenium red was significantly lower than
control at each rate of pacing (0.5 to 5 Hz; p ' 0.0003; n = 16). The
cells contracted in response to stimulation in the presence of ruthenium
red. During pacing at 5 Hz, mitochondrial NAD(P)H was significantly
and reversibly reduced in the control cells (p ' 0.0001; n = 35), as well
as in the ruthenium red-treated cells (p ' 0.0001; n = 16). * =
significantly different from initial value, within the same treatment
group. t = significantly different from control, with same rate of
stimulation. Data are mean ± SE. Perfusion and stimulation protocols
were the same as those described in Fig. 2.
pared to rest, and stimulation at 5 Hz increases oxygen
consumption about sevenfold. The increased oxygen con-
sumption at 5 Hz compared to 0.5 Hz is highly signifi-
cant, in both control cells (n = 4) and ruthenium-treated
cells (n = 2) (p < 0.005 and p < 0.02, respectively). The
normalized oxygen consumption is not significantly dif-
TABLE I PCr/ATP levels during 5 Hz stimulation
PCr/ATP during
Substrate PCr/ATP at rest stimulation
Glucose + ,3-OH butyrate 1.76 ± 0.08 1.68 ± 0.12 (n = 10)
Glucose + /3-OH butyrate
+ ruthenium red 1.71 ± 0.08 1.64 ± 0.06 (n = 6)
These data are not significantly different, p > 0.05.
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level of mitochondrial NADH via stimulation of mito-
chondrial dehydrogenases. Endogenous fluorescence
emission from heart cells comes mainly from total mito-
chondrial reduced nicotinamides, with negligible contri-
bution from cytosolic pyridine nucleotides (Nuutinen,
1984). The extent of reduction of mitochondrial NAD(P)
is in near equilibrium with the extent of reduction of
other components of the electron transport chain as well
as with A,t (Ugurbil and From, 1993). The extent of
reduction of these pools is governed by nonequilibrium
inputs and outputs to the electron transport chain. The
nonequilibrium inputs and outputs are 1) replenishment
of oxygen supply, 2) replenishment of substrate, and 3)
dissipation of the electrochemical gradient across the
inner mitochondrial membrane, which in turn is governed
by the rate of ATP utilization. In the studies reported
here, oxygen supply was not limiting (White and Witten-
berg, 1993) and substrate supply included both glucose
and fatty acid. This enabled us to study the consequences
of interventions that change intracellular calcium levels
on the extent of reduction of mitochondrial NAD(P)H
during a standardized increase in ATP utilization. Our
experiments provide a direct measure of changes in the
steady-state NADH levels of heart cells before, during,
and after pacing. A reversible significant decrease in the
NADH level of -30% of the initial level is observed
when cells are paced at 5 Hz. Under experimental con-
ditions that affect the initial NADH level (e.g., absence of
f3-OH butyrate substrate or presence of ruthenium red),
the absolute magnitude of the decrease- is not signifi-
cantly different, but the direction of reversible significant
change is always the same when the cells contract spe-
cifically in response to repetitive stimulation.
The isolated heart cell model
There are several advantages to the use of single, function-
ally intact isolated heart cells for the study of the effects of
calcium on mitochondrial NADH during electrical pacing.
The heart cells are architecturally and metabolically intact,
with maintenance of intracellular compartmentation and
energy reserves as in the whole heart. Oxygen supply can be
maintained at nonlimiting rates as the pacing rate is in-
creased; that is not possible in the whole perfused heart,
where oxygen supply is modulated by vascular and humoral
controls. Note that Zhang et al. (1995) showed that at high
work loads, the beating in situ heart is limited in its energy
production by the availability of blood flow and oxygen
supply. Accordingly, we are able to study the interactions of
changes in intracellular calcium and mitochondrial NADH,
without complications due to insufficient oxygen supply.
We assume that in the whole heart there may be modulation
of the basic reactions described in its component cells, and
throughout the discussion we relate our findings (where
possible) to those described in the blood-perfused whole
heart, which is a more integrated model. Although work
2795White and Wittenberg
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output in the unloaded heart cells is considerably less than
that of the whole heart, oxygen uptake can be stimulated up
to sevenfold by pacing. Our basic finding that increased
intracellular calcium during pacing does not increase the
level of mitochondrial NADH when oxygen supply is not
limiting must be as valid for the whole heart as it is for
isolated heart cells.
The effect of oxygen supply on
mitochondrial NADH
Mitochondrial NADH reflects the oxygen supply to the
mitochondria, and mitochondrial NADH levels increase as
the oxygen supply to the heart cells is diminished (White
and Wittenberg 1993). NADH builds up as a consequence
of the decreased availability of oxygen to react with cyto-
chrome oxidase, a rate-limiting step in electron transport
(see Fig. 6). During electrical pacing, oxygen consumption
of the heart cells is increased sevenfold (see Fig. 5) to
maintain mitochondrial oxidative phosphorylation at a rate
commensurate with the rate of ATP utilization. Note that a
20-fold increase in respiration is observed when the elec-
trochemical gradient is dissipated with 8 ,uM carbonyl cy-
anide-m-chlorophenylhydrazone, a proton ionophore.
Therefore the respiratory stimulation we observe is -30%
of maximum respiration. During 5 Hz stimulation, the mea-
sured oxygen levels are always above 20 mm Hg, as mea-
sured by the oxygen electrode. In the isolated cell system,
with short diffusion distances, mitochondrial oxygen uptake
becomes limited only below 5 mm Hg (Wittenberg and
Wittenberg 1985). Under the present conditions of abundant
oxygen supply, we observe a 30% decrease in NADH levels
during (increased) pacing at 5 Hz. The decrease in NADH
levels during increased pacing is in accord with experiments
in whole heart by Conley et al. (1991), who took great care
to limit their observations to aerobic regions of the working
heart, and by Scott et al. (1994). Previous reports (Katz et
al., 1987) that mitochondrial NAD(P)H of the beating heart
is progressively increased with increased work output prob-
ably reflect compromised oxygen delivery to the area under
observation (White and Wittenberg, 1993; Heineman and
Balaban, 1993) rather than an effect of increased intracel-
lular calcium on activation of mitochondrial dehydroge-
nases.
The effect of substrate supply on
mitochondrial NADH
The heart preferentially uses fatty acid substrates, aug-
mented by glucose, during work; ketone bodies (such as
j3-OH butyrate) and glucose are normally present in blood.
We show here that the addition of 13-OH butyrate as a
substrate substantially increases mitochondrial NAD(P)H
levels (Fig. 1) and PCr/ATP in resting and stimulated heart
cells (see Table 1). The observed increase in high energy
(1991) using dog heart. Accordingly, 13-OH butyrate aug-
mented by glucose was used in all subsequent experiments
reported here. Despite the increase in mitochondrial
NAD(P)H observed at rest in the presence of 13-OH bu-
tyrate, we saw a reversible decrease in mitochondrial
NAD(P)H of -0.10 of total mitochondrial NAD(P) during
pacing at 5 Hz in these well oxygenated cells. Possibly the
13-OH butyrate dehydrogenase reaction specifically influ-
ences the supply and regulation of reducing equivalents to
NADH. At steady state, the rate of inflow of reducing
equivalents to NADH must equal the rate of outflow, and in
addition must maintain the level of the NADH pool. Be-
cause NADH levels are higher in the presence of glucose
plus 13-OH butyrate, the rate of supply of NADH is greater
in this condition than in the presence of glucose alone.
The effect of the rate of ATP utilization on
mitochondrial NADH
During pacing, sarcoplasmic calcium levels increase, initi-
ating contraction and stimulating ATP utilization at the
myofilaments. Change in the extent of reduction of mito-
chondrial NAD(P) reflects change in the magnitude of A/
(Ugurbil and From, 1993). The Ali is the sum of the
mitochondrial membrane potential and the pH gradient
across the mitochondrial membrane. In the presence of
carbonyl cyanide-m-chlorophenylhydrazone, NADH be-
comes fully oxidized, and the measured value of NADH
drops to zero. We showed previously that pacing at 5 Hz
does not change cytoplasmic pH as measured with an in-
tracellular pH indicator (White and Wittenberg, 1993), so
the measured decrease in NADH levels must reflect a
change in Ap,.
Wan et al. (1993) reported that increased pacing of whole
heart, sufficient to increase respiration fourfold, decreased
the mitochondrial membrane potential measured with volt-
age-sensitive dyes. This is consistent with the decreased
NAD(P)H that we observed in rapidly paced cells with a
six- to sevenfold increase in respiration.
The ability of the cells to withstand the stimulation pro-
tocol without significant change in the PCr/ATP level
shows that the energy status of the cells is maintained.
These observations suggest that at increased work a new
steady-state balance is achieved between the rate of sub-
strate supply to the electron transport chain and the rate of
utilization of A[L, whereas ATP and ADP levels are main-
tained.
The effect of changes in intracellular calcium on
mitochondrial NADH
Increased mitochondrial calcium during pacing
During electrical pacing of isolated heart cells, sarcoplasmic
and mitochondrial Ca2+ (Ca,) are substantially increased to
-750 nM, and the active form of pyruvate dehydrogenase is
increased to 50% of total (Di Lisa et al., 1993). The activity
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phosphates is in accord with data reported by Kim et al.
Calcium Effects on NAD(P)H
glucose - yruvate B-OH butyrate
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+
ATP
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myofilaments
FIGURE 6 Some relevant mitochondrial reactions during pacing. Two of the reactions shown operate far from equilibrium in paced cells. These are the
reaction of cytochrome oxidase with oxygen and the reaction of FOFIATP synthase with Ali, ADP, and Pi (Ugurbil and From, 1993). Other reactions of
the electron transport chain operate near equilibrium. In steady state, NADH concentration is linked to A/,, such that the decreasing NADH concentration
reflects decreased Alx. The major net reaction of the electron transport chain is oxidation of NADH by oxygen delivered by myoglobin (MbO2) at the outer
mitochondrial membrane, with generation of Ali across the inner mitochondrial membrane. Ali is dissipated by ATP synthesis. Repetitive pacing at 5 Hz
causes a sevenfold increase in respiratory oxygen uptake. The oxygen reacts with cytochrome oxidase at the inner mitochondrial membrane, electron
transport along the mitochondrial chain is enhanced, and there is increased proton translocation across the mitochondrial membrane to augment A/,. The
increased activity of the reactions of the electron transport chain and ATP synthase tend to decrease NADH by oxidation to NAD+. In turn, NADH is
replenished by dehydrogenase reactions. Intracellular calcium increases during pacing, increasing ATP utilization at the myofilaments, and mitochondrial
calcium is increased by calcium entry through the Ca21 uniporter. Four mitochondrial dehydrogenases (bold type in boxes) that generate NADH are
activated by calcium so that the rate of delivery of NADH to the electron transport chain can be enhanced.
MbO2
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of several other mitochondrial dehydrogenases indicated in
Fig. 6 are enhanced by increased calcium, and the rate of
delivery of reducing equivalents to NADH can be increased
to meet the increased demand for electron transport. It was
suggested that Ca2+ activation of dehydrogenase activity
might be expected to increase mitochondrial NAD(P)H lev-
els (McCormack et al., 1990). Our results, under conditions
in which oxygen supply is not limiting (Figs. 1 and 3), show
that steady-state mitochondrial NAD(P)H decreases during
rapid pacing of isolated myocyte.
Potassium channel blockers were shown to depolarize
heart cells and to broaden the cardiac action potential (Giles
and Imaizumi, 1988). Depolarization would reduce the po-
tential energy available for Na/Ca exchange, and Ca, levels
would be expected to increase. Low Na+ medium increases
Ca, (Doeller and Wittenberg, 1990; Gupta and Wittenberg,
1993), but we showed previously that there was no increase
in mitochondrial NAD(P)H (White and Wittenberg, 1993).
In that system, electrical pacing was not possible. In this
report, we show that when Ca, is expected to further in-
crease by 5-Hz pacing in the presence of K+ channel
blockers, mitochondrial NAD(P)H decreases to a signifi-
cantly greater extent than control (Fig. 3). Thus mitochon-
drial calcium levels increase during pacing, and the activity
of mitochondrial dehydrogenases is said to be enhanced
without leading to a buildup of mitochondrial NADH.
Inhibition of contraction: ryanodine and verapamil
Ryanodine (at 5 AM) maintains sarcoplasmic reticulum
calcium channels in the open position, thus abolishing cal-
cium-induced calcium release (Hille, 1984). Under these
conditions, the cells do not contract in response to electrical
stimulation. In contrast to control cells, mitochondrial
NAD(P)H does not change during rapid stimulation (Fig. 2).
Verapamil plus NiCl2 (which blocks L-type and T-Type
Ca2+ channels, respectively) inhibits entry of extracellular
Ca2+ into the sarcoplasm (Hille, 1984). We find that vera-
pamil plus NiCl2 prevents contraction and the marked drop
in mitochondrial NAD(P)H normally observed during 5 Hz
pacing in single myocytes. Our findings are in accord with
the report of Scott et al. (1994) that blocking increased work
output in the perfused heart with 2,3-butanedione mon-
oxime also blocked the decrease in mitochondrial
NAD(P)H. We conclude that electrical stimulation that does
not lead to contraction of heart cells does not change their
mitochondrial NAD(P)H levels.
Decreased mitochondrial calcium: ruthenium red
In this study we use ruthenium red to specifically block
calcium entry into mitochondria via the Ca2+ uniporter (see
Fig. 6; Moore, 1971; Gunter and Pfeiffer, 1990). Rutheni-
um-red treatment has multiple consequences on cardiac
mitochondrial function: 1) cytoplasmic calcium levels are
maintained, (Hansford 1994); 2) calcium-dependent activa-
mack and England, 1983; Hansford 1987); 3) activation of
mitochondrial ATPase/synthase during pacing is blocked
(Harris and Das, 1991); and 4) PCr levels decrease and ADP
levels increase in response to increased work load (e.g.,
Katz et al., 1988; Unitt et al. 1989). In our heart cell model,
however, the PCr level does not decrease significantly dur-
ing stimulation sufficient to stimulate oxygen consumption
sevenfold (See Table 1). This indicates a stable energetic
status, which may be attributed to the high nonlimiting
oxygenation levels that we are able to achieve in the heart
cell perfusion. Thus the rate of oxidative phosphorylation is
sufficient to maintain PCr levels at increased energy de-
mand. Zhang et al. (1995) recently reported that in the
blood-perfused beating heart at high work loads, the ATP
synthesis rate was limited by blood flow and oxygen supply.
At the dose used here, we found that ruthenium red-
treated cells contract synchronously in response to electrical
stimulation, indicating that excitation-contraction coupling
remains intact. Therefore sarcolemmal calcium channels
and sarcoplasmic calcium-release channels are not blocked.
Because Ca2+ entry into mitochondria is blocked at this
dose of ruthenium red, we conclude that Ca2+ entry into
mitochondria is not a prerequisite for contraction mainte-
nance.
The NADH level of cells in the presence of ruthenium
red is significantly lower than that of control cells paced
at 0.5 Hz. Rapid pacing (5 Hz) brings about a further 25%
decrease in mitochondrial NAD(P)H (see dark bars in
Fig. 4) and a significant increase in oxygen consumption
(see Fig. 5). Assuming that ruthenium red does not in-
crease the rate of ATP utilization (as indicated by the
oxygen consumption data), a plausible explanation might
be that the rate of supply of reducing equivalents is
decreased because of decreased activation of dehydroge-
nases, and a new lower steady-state level of NAD reduc-
tion is observed.
Mitochondrial calcium in cells paced at 0.5 Hz in the
presence of f3 agonists is -200 nM (Di Lisa et al., 1993).
Our data strongly suggest that mitochondrial calcium at
concentrations below 200 nM dominates the regulation of
NAD(P) reduction.
SUMMARY
We tested the hypothesis that increased intracellular
Ca2+ levels during increased work regulates the steady-
state level of mitochondrial NADH by stimulation of
mitochondrial dehydrogenases. Steady-state mitochon-
drial NAD(P)H of well oxygenated control cells (see Fig.
1 and the lightly shaded bars in Fig. 2) drops significantly
and reversibly by -30% during 5 Hz pacing. This re-
sponse is blocked when contraction is blocked. The mi-
tochondrial Ca2+ is known to increase from 200 nM to
700 nM during rapid pacing of heart cells. Mitochondrial
Ca2+ must be below control levels in the presence of
tion of mitochondrial dehydrogenases is blocked (McCor-
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ruthenium red. Blocking the entry of Ca2+ into the mi-
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tochondria does lead to a decrease in NADH levels
compared with controls at all rates of pacing. Among
other possibilities, this may imply that dehydrogenase
activity dominates regulation of NAD(P)H levels in this
range of mitochondrial calcium concentration.
The simplest explanation of these findings is that in the
absence of pharmacological intervention, mitochondrial
ATP synthase activity is stimulated by increased ATP de-
mand at the myofilaments during pacing. The rate of sub-
strate supply to the electron transport chain during pacing
must be increased sufficiently to maintain ATP levels but at
a new lower steady-state level of NADH. In this situation,
other factors may override dehydrogenase control of the
NAD(P)H level.
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